The merger close and reverse split are procedural steps to maintain Nasdaq listing. Monitor for the actual closing date and any updates on remaining conditions. The new ticker 'NIKI' will reflect the combined entity's diagnostics focus.
Price Chart
Executive Summary
Aptorum Group announced that its merger with DiamiR Biosciences is expected to close on or about July 20, 2026, with the combined entity to be renamed Niki BioSolutions, Inc. and trade on Nasdaq under the ticker 'NIKI'. A 1-for-10 reverse share split and redomestication to Delaware will also be effected in connection with the merger.
Key Facts
- Merger with DiamiR Biosciences expected to close on or about July 20, 2026.
- Post-merger company to be named Niki BioSolutions, Inc., trading under ticker 'NIKI' on Nasdaq.
- 1-for-10 reverse share split of class A and class B ordinary shares approved by shareholders on June 9, 2026.
- Reverse split reduces outstanding class A shares from ~6,346,823 to ~634,682 and class B from ~1,796,934 to ~179,693.
- Aptorum to redomicile as a Delaware company.
- No fractional shares will be issued; fractional shares rounded up to nearest whole number at broker level.
Financial Impact
Reverse split reduces share count by 90% but does not change percentage ownership; no deal value disclosed.
Risk Factors
- Merger may not close if remaining customary conditions are not satisfied or waived.
- Post-merger entity may face challenges in maintaining Nasdaq listing compliance beyond bid price.
- No financial terms of the merger disclosed; valuation uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3328636 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 8-K | — | awaiting T+1 | — | — |
Oct 9, 2026 18d ago | 8-K | — | awaiting T+1 | — | — |
Oct 9, 2026 18d ago | 424B5 | — | awaiting T+1 | — | — |
Jul 20, 2026 14w ago | 8-K | $8.83 $9.54 | ▲ +8.04% | ▲ +7.21% | — |
Jul 16, 2026 14w ago | Press Release | $0.6924 $0.7000 | ▲ +1.10% | ▲ +2.09% | — |
Jun 10, 2026 19w ago | 6-K | $0.9038 $0.8900 | ▼ −1.53% | ▼ −3.23% | — |
Jun 4, 2026 20w ago | EFFECT | $1.09 $1.01 | ▼ −7.34% | ▼ −4.74% | — |
May 14, 2026 23w ago | 6-K | $0.8230 $0.8570 | ▼ −4.13% | ▼ −4.19% | — |
Mar 27, 2026 30w ago | 20-F | $0.8380 $0.7960 | ▲ +5.01% | ▲ +7.90% | — |
Mar 6, 2026 33w ago | Press Release | $0.8000 $0.7930 | ▲ +0.88% | ▲ +0.69% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers